New asthma inhaler put to the test
NCT ID NCT05735431
Summary
This study aimed to see if a new, lower-dose asthma inhaler works as well as a standard one for controlling moderate asthma. It planned to enroll people aged 12 and older with moderate asthma. The main goal was to compare how well the two inhalers helped patients breathe over a 12-week period. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eurofarma Laboratorios S.A
São Paulo, 06696-000, Brazil
Conditions
Explore the condition pages connected to this study.